TRIM11 Upregulation Contributes to Proliferation, Invasion, and EMT of Hepatocellular Carcinoma Cells
Document Type: Research Article
Affiliations: 1: Department of Abdominal Surgery, Zhejiang Cancer Hospital, Hangzhou, P.R. China 2: Department of Integrated Chinese and Western Medicine, Zhejiang Cancer Hospital, Hangzhou, P.R. China 3: Zhejiang Institute for Food and Drug Control, Hangzhou, P.R. China 4: Department of Colorectal Surgery, Zhejiang Cancer Hospital, Hangzhou, P.R. China
Publication date: May 24, 2017
This article was made available online on December 15, 2016 as a Fast Track article with title: "TRIM11 Upregulation contributes to proliferation, invasion and EMT of hepatocellular carcinoma cells".
- Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.